NantHealth, Inc.
NHIQ
$0.05
$0.0494,900.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -14.99M | -17.49M | -12.24M | -25.66M | -13.66M |
| Total Depreciation and Amortization | 4.83M | 1.39M | 1.41M | 1.43M | 1.47M |
| Total Amortization of Deferred Charges | 2.61M | 1.92M | 1.67M | 2.69M | 2.58M |
| Total Other Non-Cash Items | 2.31M | 4.84M | -2.93M | 9.86M | -2.83M |
| Change in Net Operating Assets | -2.42M | 2.97M | 5.52M | 4.63M | 7.41M |
| Cash from Operations | -7.65M | -6.37M | -6.57M | -7.05M | -5.02M |
| Capital Expenditure | 11.00K | -810.00K | -1.26M | -2.32M | -1.30M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 11.00K | -810.00K | -1.26M | -2.32M | -1.30M |
| Total Debt Issued | 0.00 | 0.00 | 22.50M | 11.00M | 1.66M |
| Total Debt Repaid | 0.00 | 0.00 | -560.00K | -553.00K | -545.00K |
| Issuance of Common Stock | 7.50M | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -425.00K | -1.34M | -- | -- |
| Cash from Financing | 7.50M | -425.00K | 20.60M | 10.45M | 1.11M |
| Foreign Exchange rate Adjustments | -155.00K | -372.00K | -376.00K | 38.00K | 131.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -298.00K | -7.98M | 12.39M | 1.12M | -5.08M |